Targeting glucose metabolism for treatment of COVID-19.
Targeting glucose metabolism for treatment of COVID-19.
复制标题
DOI:
10.1038/s41392-021-00532-4
复制
发表时间:
2021-03-06
影响因子:
39.3
通讯作者:
Azizi Z
中科院分区:
文献类型:
--
作者:
Ardestani A;Azizi Z
A recent study published in Cell Metabolism by Codo et al. 1 shows that metabolic rewiring of human monocytes by SARS-CoV-2 infection cultured under high glucose highly induces viral replication and cytokine production compromising T-cell response and function. Ultimately, this triggers lung epithelial cell death and, mechanistically, provides an explanation why people with diabetes might be more susceptible to develop severe COVID-19. COVID-19 caused by the SARS-CoV-2 represents a significant public health burden; its high prevalence worldwide has dramatic consequences on the society at all levels. Obesity and related metabolic diseases particularly type 2 diabetes (T2D) are linked with more devastating COVID-19 disease courses. 2 Recent epidemiological data demonstrate that rate of COVID-19 induced morbidity as well as mortality is markedly higher in people with obesity and T2D. 2 Consistently, multiple clinical studies including a retrospective examination of a large cohort of COVID-19 patients have shown that poorly controlled blood glucose levels are associated with highest COVID-19 mortality rates. 2 This suggests that COVID-19 pathogenesis and the regulation of metabolism in the host are intimately connected. Little is known about the molecular mechanisms of deregulated glucose metabolism, especially under insulin therapy, that determine vulnerability of cells and organs in a diabetic environment to a severe SARS-CoV-2 disease outcome.Viruses alter the host cell metabolism in order to make optimal conditions for their rapid and efficient replication and spread. One key particular example is the enhanced uptake of important nutrients such as glucose to support metabolic signaling, ie, aerobic glycolysis, a primary pathway of glucose metabolism and its by-products for biosynthetic reactions. Abnormal glucose metabolism primarily caused by impaired insulin secretion and/or action is a characteristic feature of T2D and affects several tissues highly important for the regulation of whole body metabolism, such as liver, adipocytes, muscle, pancreatic islets, and immune cells. The increased glucose metabolism imposed by sustained hyperglycemia may enhance SARS-CoV-2’s entry and subsequent replication, as well as an exacerbated immune response in individuals with diabetes. Thus, a disrupted glucose metabolism and metabolic derangement in diabetes may be an intrinsic cellular strategy that favors SARS-CoV-2 pathogenesis. In this context, Codo et al. 1 explored the molecular response of SARS-CoV-2 infected human monocytes under diabetic condition. The authors initially show that SARS-CoV-2 efficiently infects peripheral blood monocytes, upregulates angiotensin-converting enzyme 2 (ACE2), a key SARS-CoV-2’s receptor and highly induced proinflammatory cytokines such as TNF-α, IL-1β, and IL-6. This is consistent with the altered innate immune response and excessive inflammatory cytokine production, the so-called “cytokine storm”
登录
查看更多内容
影响因子:
13.6
作者:
Wang, Qiming;Fang, Peining;Liu, Shi
通讯作者:
Liu, Shi
影响因子:
29
作者:
Codo, Ana Campos;Davanzo, Gustavo Gastao;Moraes-Vieira, Pedro M.
通讯作者:
Moraes-Vieira, Pedro M.
影响因子:
29
作者:
Rodriguez, Arianne E.;Ducker, Gregory S.;Chandel, Navdeep S.
通讯作者:
Chandel, Navdeep S.
DOI:
10.1038/s41574-020-00435-4
发表时间:
2021-01
期刊:
Nature reviews. Endocrinology
影响因子:
--
作者:
Lim S;Bae JH;Kwon HS;Nauck MA
通讯作者:
Nauck MA
影响因子:
64.8
作者:
Bojkova, Denisa;Klann, Kevin;Muench, Christian
通讯作者:
Muench, Christian